Responsiveness of various reservoir species to oral rabies vaccination correlates with differences in vaccine uptake of mucosa associated lymphoid tissues.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 02 2020
Historique:
received: 06 06 2019
accepted: 03 02 2020
entrez: 21 2 2020
pubmed: 23 2 2020
medline: 13 11 2020
Statut: epublish

Résumé

Oral rabies vaccination (ORV) is highly effective in foxes and raccoon dogs, whereas for unknown reasons the efficacy of ORV in other reservoir species is less pronounced. To investigate possible variations in species-specific cell tropism and local replication of vaccine virus, different reservoir species including foxes, raccoon dogs, raccoons, mongooses, dogs and skunks were orally immunised with a highly attenuated, high-titred GFP-expressing rabies virus (RABV). Immunofluorescence and RT-qPCR screenings revealed clear differences among species suggesting host specific limitations to ORV. While for responsive species the palatine tonsils (tonsilla palatina) were identified as a main site of virus replication, less virus dissemination was observed in the tonsils of rather refractory species. While our comparison of vaccine virus tropism emphasizes the important role that the tonsilla palatina plays in eliciting an immune response to ORV, our data also indicate that other lymphoid tissues may have a more important role than originally anticipated. Overall, these data support a model in which the susceptibility to oral live RABV vaccine infection of lymphatic tissue is a major determinant in vaccination efficacy. The present results may help to direct future research for improving vaccine uptake and efficacy of oral rabies vaccines under field conditions.

Identifiants

pubmed: 32076025
doi: 10.1038/s41598-020-59719-4
pii: 10.1038/s41598-020-59719-4
pmc: PMC7031338
doi:

Substances chimiques

Antibodies, Viral 0
RNA, Viral 0
Rabies Vaccines 0
Green Fluorescent Proteins 147336-22-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2919

Références

Acta Vet Hung. 2001;49(3):285-90
pubmed: 11702339
J Clin Microbiol. 2010 Nov;48(11):3970-8
pubmed: 20739489
Can J Vet Res. 1987 Jul;51(3):363-6
pubmed: 3651890
Proc Natl Acad Sci U S A. 1986 Oct;83(20):7947-50
pubmed: 3464010
J Wildl Dis. 2013 Oct;49(4):1033-6
pubmed: 24502736
Vaccine. 2001 Aug 14;19(31):4511-8
pubmed: 11483278
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709
pubmed: 25881058
Trop Med Infect Dis. 2017 Jul 21;2(3):
pubmed: 30270888
Vaccine. 2006 May 15;24(20):4386-92
pubmed: 16603277
Virus Res. 2005 Jul;111(1):101-5
pubmed: 15896409
J Wildl Dis. 2001 Jan;37(1):119-32
pubmed: 11272485
Vaccine. 2018 Feb 1;36(6):811-817
pubmed: 29325820
J Wildl Dis. 1992 Oct;28(4):629-35
pubmed: 1474662
Vaccine. 1996 Apr;14(6):465-8
pubmed: 8782341
Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120142
pubmed: 23798690
PLoS Negl Trop Dis. 2009 Dec 22;3(12):e549
pubmed: 20027214
Can J Vet Res. 1988 Jan;52(1):58-62
pubmed: 3280109
Vet J. 2015 Jan;203(1):10-7
pubmed: 25466578
J Wildl Dis. 2006 Jul;42(3):663-6
pubmed: 17092899
EMBO J. 1994 Sep 15;13(18):4195-203
pubmed: 7925265
Ann Rech Vet. 1985;16(4):327-33
pubmed: 4091486
Clin Dev Immunol. 2011;2011:472460
pubmed: 21869895
Rev Infect Dis. 1988 Nov-Dec;10 Suppl 4:S610-4
pubmed: 3060954
J Wildl Dis. 2007 Jan;43(1):124-8
pubmed: 17347402
Arch Virol. 2010 Oct;155(10):1631-41
pubmed: 20614145
J Control Release. 2014 Jan 10;173:18-31
pubmed: 24511609
Arch Virol. 1992;123(1-2):169-79
pubmed: 1550495
J Vet Med B Infect Dis Vet Public Health. 2001 Apr;48(3):179-83
pubmed: 11393813
Dev Biol (Basel). 2008;131:291-8
pubmed: 18634491
BMC Vet Res. 2018 Mar 13;14(1):90
pubmed: 29534727
Am J Epidemiol. 1971 Jun;93(6):487-90
pubmed: 4935086
Vet Res. 2017 Sep 22;48(1):57
pubmed: 28938920
J Virol. 2013 Aug;87(16):9097-110
pubmed: 23760241
Pharmazie. 2006 Jun;61(6):495-504
pubmed: 16826967
Vet Microbiol. 2007 Mar 10;120(3-4):343-51
pubmed: 17147979
Vet Res. 2018 Jul 13;49(1):61
pubmed: 30005701
Vaccine. 2008 Jul 4;26(29-30):3556-65
pubmed: 18524435
Dev Biol (Basel). 2004;119:173-84
pubmed: 15742629
Vaccine. 2008 Jan 17;26(3):419-26
pubmed: 18082293
Vaccine. 2015 Jun 17;33(27):3100-3
pubmed: 25980427
J Wildl Dis. 2002 Apr;38(2):420-7
pubmed: 12038142
Vaccine. 2014 Jun 17;32(29):3675-9
pubmed: 24814554
Can J Vet Res. 1987 Jul;51(3):367-9
pubmed: 3651891
J Immunol. 2005 May 15;174(10):6308-13
pubmed: 15879130
J Am Vet Med Assoc. 2018 Apr 15;252(8):945-957
pubmed: 29595389
Mucosal Immunol. 2008 Jan;1(1):31-7
pubmed: 19079158
Zoonoses Public Health. 2018 Jun;65(4):373-385
pubmed: 29633545
Vaccine. 2017 Jul 13;35(32):3938-3944
pubmed: 28641888
Front Vet Sci. 2018 May 18;5:91
pubmed: 29868616
Can J Vet Res. 1990 Jan;54(1):178-83
pubmed: 2306670
Dev Biol (Basel). 2008;131:257-64
pubmed: 18634487
J Virol Methods. 2013 Feb;187(2):264-70
pubmed: 23201293
J Virol. 2010 Feb;84(4):1816-27
pubmed: 19955305
Vet Microbiol. 2010 Apr 21;142(1-2):59-68
pubmed: 19857935
J Wildl Dis. 1990 Jan;26(1):99-102
pubmed: 2304207
Virology. 1990 Apr;175(2):485-99
pubmed: 2139267
Antiviral Res. 2017 Oct;146:221-232
pubmed: 28365457
J Wildl Dis. 1989 Oct;25(4):548-54
pubmed: 2810555
Vaccine. 2007 Apr 30;25(17):3409-18
pubmed: 17224221
J Wildl Dis. 2008 Oct;44(4):946-64
pubmed: 18957651
Am J Epidemiol. 1975 Feb;101(2):160-4
pubmed: 1124754
J Wildl Dis. 2012 Oct;48(4):1042-6
pubmed: 23060506
J Wildl Dis. 1991 Oct;27(4):681-4
pubmed: 1758034
Acta Vet Scand. 2011 Nov 15;53:58
pubmed: 22085767
J Am Vet Med Assoc. 2005 Sep 1;227(5):785-92
pubmed: 16178403
J Virol. 1997 Oct;71(10):7372-80
pubmed: 9311815
J Wildl Dis. 2002 Apr;38(2):428-31
pubmed: 12038143

Auteurs

Verena Te Kamp (V)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, Greifswald-Insel Riems, Germany.
Thescon GmbH, 48653, Coesfeld, Germany.

Conrad M Freuling (CM)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, Greifswald-Insel Riems, Germany.

Ad Vos (A)

Ceva Innovation Center GmbH, 06861, Dessau-Rosslau, Germany.

Peter Schuster (P)

Ceva Innovation Center GmbH, 06861, Dessau-Rosslau, Germany.

Christian Kaiser (C)

Ceva Innovation Center GmbH, 06861, Dessau-Rosslau, Germany.

Steffen Ortmann (S)

Ceva Innovation Center GmbH, 06861, Dessau-Rosslau, Germany.

Antje Kretzschmar (A)

Ceva Innovation Center GmbH, 06861, Dessau-Rosslau, Germany.

Sabine Nemitz (S)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, Greifswald-Insel Riems, Germany.
BioNTech IMFS GmbH, 55743, Idar-Oberstein, Germany.

Elisa Eggerbauer (E)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, Greifswald-Insel Riems, Germany.
Thüringer Landesamt für Verbraucherschutz, 99947, Bad Langensalza, Germany.

Reiner Ulrich (R)

Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Leipzig University, 04103, Leipzig, Germany.

Jan Schinköthe (J)

Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Leipzig University, 04103, Leipzig, Germany.

Tobias Nolden (T)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, Greifswald-Insel Riems, Germany.
ViraTherapeutics GmbH, 6020, Innsbruck, Austria.

Thomas Müller (T)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, Greifswald-Insel Riems, Germany.

Stefan Finke (S)

Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, Greifswald-Insel Riems, Germany. Stefan.Finke@fli.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH